PureTech´s Affiliate Gelesis Presents Data Supporting Lead Product Candidate´s Positive Effect on People with Prediabetes, Untreated Diabetes, and Elevated Insulin Resistance
(WorldNews Africa)

Individuals with prediabetes and those with untreated type 2 diabetes had six times higher odds to achieve >=10% weight loss compared to placebo Individuals with high insulin resistance achieved significant drop in HOMA-IR levels on treatment independent of their level of weight loss PureTech Health plc (LSE: PRTC) (`PureTech Health`), an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) Axis, is pleased to note that its affiliate Gelesis today presented clinical data at ENDO 2019, the Endocrine Society`s annual meeting, suggesting that elevated fasting plasma glucose could be a useful and unique predictor to identify individuals who...